PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “LABORATORIES, MEDICAL”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,153 records · Page 64Linked to original sources

Managing the multi-cultural laboratory, Part II: Tools for managing the differences.

This second article provides practical advice from managers in a variety of industries who have first-hand experience as multi-cultural managers. It will help laboratory professionals make practical application of two conceptual models in managing their culturally diverse employees. The advice covers such areas as performance standards, interpersonal skills, language issues, and other management practices. The first article explained what is meant by "culture" and featured the research-based model set forth by Dutch social psychologist and management consultant, Dr. Geert Hofstede. His four dimensions of culture (Power Distance, Masculinity/Femininity, Individualism/Collectivism, and Uncertainty Avoidance) provide a useful framework for assessing the different values, attitudes, and behaviors exhibited by those of different cultural backgrounds. In this article, abbreviated reference tables are presented that make these cross-cultural data more useful for management decision making. Laboratory supervisors can use both the models and the advice to challenge their own built-in cultural biases and to meaningfully interpret some of the attitudes and behaviors of culturally diverse coworkers and employees.

Communication Barriers↗

Changes in effectiveness of psychotherapeutic drug level monitoring program after lessening pharmacy involvement.

The psychotherapeutic drug monitoring policy established by the medical, laboratory, and psychopharmacy departments at Austin State Hospital allowed for psychopharmacists to schedule, interpret, and monitor antidepressant and antipsychotic plasma concentrations. A recent policy change eliminated the psychopharmacists' role in scheduling blood draws for plasma drug concentration determinations. A comparison of the use of psychotropic plasma drug concentrations before and after implementation of the policy change, with regards to appropriate disease states, indication, scheduling, and choice of drug was conducted. Despite a fourfold increase in the number of plasma drug concentrations obtained after the policy change, the physicians appeared to be aware of the steady state requirements and situations in which monitoring plasma drug concentrations was justified. The number of plasma drug concentrations that were obtained to verify a suspected drug interaction, or adverse effect, increased after the new policy was implemented. This seemingly indicates physician uncertainty in determining the clinical implication of potential drug-drug interactions and recognizing which adverse effects may be dose related.

Drug Interactions↗